Erin Garcia de Jesús

Staff Writer

Erin Garcia de Jesús is a staff writer at Science News. She holds a Ph.D. in microbiology from the University of Washington, where she studied virus/host co-evolution. After deciding science as a whole was too fascinating to spend a career studying one topic, she went on to earn a master’s in science communication from the University of California, Santa Cruz. Her writing has appeared in Nature News, Science, Eos, Smithsonian Voices and more, and she was the winter 2019 science writing intern at Science News.

All Stories by Erin Garcia de Jesús

  1. Health & Medicine

    People with rare blood clots after a COVID-19 jab share an uncommon immune response

    AstraZeneca’s and J&J’s shots are linked to antibodies that spark clots. Knowing that lets doctors ID cases and get patients the right treatment.

  2. Health & Medicine

    U.S. pauses J&J vaccine rollout after 6 people of 6.8 million get rare blood clots

    The COVID-19 vaccine’s pause is out of abundance of caution, experts say. The potentially deadly clots appear to be “extremely rare.”

  3. Health & Medicine

    AstraZeneca’s COVID-19 vaccine is tied to uncommon blood clots in rare cases

    Blood clots should be listed as a possible side effect of AstraZeneca’s vaccine, but its benefits still outweigh the risks, experts say.

  4. Health & Medicine

    4 takeaways from the WHO’s report on the origins of the coronavirus

    The leading hypothesis is that the coronavirus spread to people from bats via a yet-to-be-identified animal, but no animals have tested positive so far.

  5. Health & Medicine

    Pfizer says its COVID-19 vaccine has 100 percent efficacy in young people

    Vaccinated 12- to 15-year-olds developed higher levels of coronavirus antibodies compared with vaccinated 16- to 25-year-olds from a previous trial.

  6. Animals

    A gene defect may make rabbits do handstands instead of hop

    Mutations in a gene typically found throughout the nervous system rob rabbits of their ability to hop. Instead, the animals walk on their front paws.

  7. Health & Medicine

    AstraZeneca’s COVID-19 vaccine holds up in an updated analysis of trial data

    The redo dropped the overall efficacy of AstraZeneca’s vaccine from 79 percent to 76 percent. But a slight fluctuation is not unexpected, experts say.

  8. Health & Medicine

    AstraZeneca says its COVID-19 vaccine is 79 percent effective in a U.S. trial

    The shot was 80 percent effective at preventing illness in people 65 and older and prevented severe disease and hospitalization.

  9. Health & Medicine

    AstraZeneca’s COVID-19 vaccine isn’t tied to blood clots, experts say

    Multiple countries suspended use of AstraZeneca’s COVID-19 vaccine because of concerns about blood clots, but health authorities say the shot is safe.

  10. Health & Medicine

    We still don’t know for sure where the coronavirus came from. Here’s why

    A year into the pandemic, we know the virus probably came from bats, but how and why it leaped to humans are still unknown.

  11. Health & Medicine

    Coronavirus reinfections appear rare, especially in people younger than 65

    Previous infections provide 80 percent protection in younger people and 47 percent in those over 65. Vaccines might help boost immunity further.

  12. Health & Medicine

    50 years ago, researchers treated chronic pain with electricity

    In 1971, doctors eased chronic pain by sending electrical impulses to the spinal cord. Fifty years later, improved techniques help paralyzed people walk.